Effects of Buprenorphine and Naloxone in Opiate Addicts - 4

National Institutes of Health (NIH)

Status and phase: Completed; Phase 1

Conditions: Opioid-Related Disorders; Substance-Related Disorders

Treatments: Drug: Buprenorphine

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT00000355

NIDA-3-0012-4

Y01-3-0012-4

Details and patient eligibility

About

The purpose of this study is to evaluate the behavioral and physiological effects of buprenorphine and naloxone, both alone and in combination.

Sex: All

Ages: 21 to 59 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.